Latest News about BMY
Recent news which mentions BMY
Why Agenus Stock Skyrocketed Today
Today 16:20 EDT
From Motley Fool
From Benzinga
After a Blowout Quarter, Is AbbVie Stock a Buy?
Today 9:28 EDT
From Motley Fool
Bristol Myers Inks $1.6B Licensing Agreement For Agenus' Bispecific Antibody Program In Solid Tumors
Today 9:16 EDT
From Benzinga
From Benzinga
The 3 Smartest Stocks to Buy in a Reopening Economy
May 17, 2021
From Motley Fool
From Benzinga
From Motley Fool
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
May 15, 2021
From Benzinga
7 Reddit Penny Stocks Promising to Cure Cancer
May 14, 2021
From InvestorPlace
2 Top Healthcare Stocks for 2021 and Beyond
May 14, 2021
From Motley Fool
From Benzinga
Why These 3 Top Stocks Are Better Buys Than Dogecoin
May 12, 2021
From InvestorPlace
From Benzinga
Why Is No One Talking About Dr. Reddy's Stock?
May 11, 2021
From Motley Fool
3 Embarrassingly Cheap Dividend Stocks
May 09, 2021
From Motley Fool
4 Surefire Stocks to Buy With $10,000 Right Now
May 08, 2021
From Motley Fool
From Motley Fool
2 Top Stocks to Buy and Hold for 10 Years
May 04, 2021
From Motley Fool
From Motley Fool
Tickers
BMY
From Motley Fool
From Benzinga
From Motley Fool
Better Buy for 2021: AbbVie or Merck?
May 01, 2021
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
April 30, 2021
From Benzinga
Bristol-Myers Squibb (BMY) Q1 2021 Earnings Call Transcript
April 30, 2021
Tickers
BMY
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.